MedTrace Logo

Optimal Sensing in Atrial Tachyarrhythmia's Study

NCT01074749 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 111

Last updated 2019-02-04

No results posted yet for this study

Summary

The aim of the study is the comparison of two different leads in their capabilities to detect episodes and duration of paroxysmal atrial fibrillation (AF) and atrial tachyarrhythmia (AT), and the rejection of far field sensing of the far field R-wave (FFRW).

Conditions

  • Sick Sinus Syndrome
  • Paroxysmal Atrial Fibrillation

Interventions

DEVICE

Accent Pacemaker

Implantation of pacemaker

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Willem De Voogt, MD PhD · St Lucas Andreas Hospital Amsterdam, Netherlands

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2014-04-30
Completion
2014-07-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01074749 on ClinicalTrials.gov